V015-5665 Screening compound: 3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-1,2-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea

V015-5665 Screening compound: 3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-1,2-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea
V015-5665 Screening compound: 3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-1,2-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-5665
3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-1,2-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-5665

Molecular Formula

C30H39N5O3 (C30 H39 N5 O3)

Compound Name

3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-1,2-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea

IUPAC name

3-(4-methylphenyl)-1-{[5-(2-methylpiperidin-1-yl)-3-phenyl-12-oxazol-4-yl]methyl}-1-[2-(morpholin-4-yl)ethyl]urea

SMILES

CC(CCCC1)N1c1c(CN(CCN2CCOCC2)C(Nc2ccc(C)cc2)=O)c(-c2ccccc2)no1

InChI

InChI=1S/C30H39N5O3/c1-23-11-13-26(14-12-23)31-30(36)34(17-16-33-18-20-37-21-19-33)22-27-28(25-9-4-3-5-10-25)32-38-29(27)35-15-7-6-8-24(35)2/h3-5,9-14,24H,6-8,15-22H2,1-2H3,(H,31,36)/t24-/m0/s1

InChI Key

PBRJUTBOZTZLHG-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD19883467

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.67

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.587

Distribution Coefficient, logD

4.339

Water Solubility, LogSw

-4.17

Polar Surface Area

62.451

Acid Dissociation Constant (pKa)

14.01

Base Dissociation Constant (pKb)

7.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.70

V015-5665 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Lipid Metabolism Library (9174 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V015-5665 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-5665?
Check Price and Availability of V015-5665, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-5665 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-5665
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-5665
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-5665 available by request